Drug Trial Radar · NCT06585449
A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
66
Planned (sponsor's estimate)
Start
Oct 14, 2024
Primary completion
Jul 5, 2028
Study completion Jul 5, 2028
Sponsor
- Lead sponsor
- Alnylam PharmaceuticalsAlnylam Pharmaceuticals (ALNY)
- Sponsor type
- Industry
- First posted
- Sep 5, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 25 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of single or repeat doses of ALN-HTT02.
Conditions
- Huntington's Disease
Interventions
ALN-HTT02Drug
ALN-HTT02 will be administered intrathecally
PlaceboDrug
Placebo will be administered intrathecally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of Adverse Events (AEs) in the Double-blind Part of the StudyTime frame: Up to 12 months
- Frequency of AEs in the Open-label Part of the StudyTime frame: Up to 12 months
- Frequency of AEs in the OLE Part of the StudyTime frame: Up to 36 months
Locations
19 sites in 3 countries. Site status is shown where the registry gives one.
Clinical Trial Site
Edmonton, Canada · Recruiting
Clinical Trial Site
Montreal, Canada · Recruiting
Clinical Trial Site
Ottawa, Canada · Recruiting
Clinical Trial Site
Vancouver, Canada · Recruiting
Clinical Trial Site
Berlin, Germany · Recruiting
Clinical Trial Site
Bochum, Germany · Recruiting
Clinical Trial Site
Bonn, Germany · Recruiting
Clinical Trial Site
Dresden, Germany · Recruiting
Clinical Trial Site
Münster, Germany · Recruiting
Clinical Trial Site
Taufkirchen, Germany · Recruiting
Clinical Trial Site
Ulm, Germany · Recruiting
Clinical Trial Site
Birmingham, United Kingdom · Recruiting
Clinical Trial Site
Cambridge, United Kingdom · Recruiting
Clinical Trial Site
Cardiff, United Kingdom · Recruiting
Clinical Trial Site
Glasgow, United Kingdom · Recruiting
Clinical Trial Site
Greater Manchester, United Kingdom · Recruiting
Clinical Trial Site
London, United Kingdom · Recruiting
Clinical Trial Site
Oxford, United Kingdom · Recruiting
Clinical Trial Site
Plymouth, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.